Literature DB >> 2916668

Downregulation and desensitization of A1-adenosine receptors in embryonic chicken heart.

J Shryock1, A Patel, L Belardinelli, J Linden.   

Abstract

Downregulation of cardiac A1-adenosine receptors and desensitization of the negative inotropic response to adenosine were examined 44 h after pretreatment of 15-day-old chick embryos with phenylisopropyladenosine (R-PIA) or vehicle. The number of A1-adenosine receptors, assessed by 125I-aminobenzyladenosine (125I-ABA) binding to crude cardiac membranes, was decreased by 63% (P less than 0.001) after pretreatment of embryos with 1 mumol of R-PIA, from 16.7 +/- 2.4 to 6.2 +/- 1.4 (SD) fmol/mg protein (n = 6). The KD of 125I-ABA binding to the remaining receptors did not differ significantly from control (0.71 +/- 0.45 vs. 0.79 +/- 0.57 nM). A maximally effective concentration of R-PIA (10(-5) M) decreased the developed tension of electrically paced right ventricular (RV) muscle strips from control embryos by 76 +/- 6% (mean +/- SD, n = 7) from its forskolin-stimulated plateau level, whereas the developed tension of strips from R-PIA-pretreated embryos was decreased significantly less, by 38 +/- 4% (P less than 0.001). The potency of R-PIA and the efficacy and potency of carbachol to decrease contractile tension were not changed. The data suggest that chronic exposure of the heart to R-PIA can produce downregulation of A1-adenosine receptors and homologous desensitization of the negative inotropic response to adenosine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916668     DOI: 10.1152/ajpheart.1989.256.2.H321

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

Review 2.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

3.  Purification of A1 adenosine receptor-G-protein complexes: effects of receptor down-regulation and phosphorylation on coupling.

Authors:  Z Gao; A S Robeva; J Linden
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

4.  Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells.

Authors:  D Vendite; J M Sanz; D M López-Alañon; J Vacas; A Andrés; M Ros
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate.

Authors:  Nissim Balas; Michael Arad; Babeth Rabinowitz; Asher Shainberg
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

6.  Effects of theophylline and dibutyryl-cAMP on adenosine receptors and heart rate in cultured cardiocytes.

Authors:  D el-Ani; K A Jacobson; A Shainberg
Journal:  J Basic Clin Physiol Pharmacol       Date:  1996

7.  The effect of calcium removal on the suppression by adenosine of epileptiform activity in the hippocampus: demonstration of desensitization.

Authors:  H Hosseinzadeh; T W Stone
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Sunny Kumar; Sandeep Sheth; Tejbeer Kaur; Leonard P Rybak; Vickram Ramkumar
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-14       Impact factor: 4.249

9.  Isolation and characterization of an avian A1 adenosine receptor gene and a related cDNA clone.

Authors:  J S Aguilar; F Tan; I Durand; R D Green
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 10.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.